BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35511640)

  • 21. TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases.
    Tjota MY; Sharma A; Wanjari P; Fitzpatrick C; Segal J; Antic T
    Hum Pathol; 2023 Apr; 134():124-133. PubMed ID: 36592877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma.
    Wang Y; Zhao P; Wang L; Wang J; Ji X; Li Y; Shi H; Li Y; Zhang W; Jiang Y
    Pathol Res Pract; 2022 Jul; 235():153960. PubMed ID: 35653922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSC/MTOR -associated Eosinophilic Renal Tumors Exhibit a Heterogeneous Clinicopathologic Spectrum : A Targeted Next-generation Sequencing and Gene Expression Profiling Study.
    Xia QY; Wang XT; Zhao M; He HY; Fang R; Ye SB; Li R; Wang X; Zhang RS; Lu ZF; Ma HH; Wang ZY; Rao Q
    Am J Surg Pathol; 2022 Nov; 46(11):1562-1576. PubMed ID: 35980750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathological features of hybrid oncocytic/chromophobe renal cell tumor].
    Wang Y; Chong DC; Xin FJ; He B; Liu XL; Li YJ; Zhang W; Jiang YX
    Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):97-102. PubMed ID: 33535302
    [No Abstract]   [Full Text] [Related]  

  • 26. Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1.
    Morini A; Drossart T; Timsit MO; Sibony M; Vasiliu V; Gimenez-Roqueplo AP; Favier J; Badoual C; Mejean A; Burnichon N; Verkarre V
    Mod Pathol; 2022 Mar; 35(3):352-360. PubMed ID: 34531523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophilic Vacuolated Tumor of the Kidney: A Review of Evolving Concepts in This Novel Subtype With Additional Insights From a Case With MTOR Mutation and Concomitant Chromosome 1 Loss.
    Kapur P; Gao M; Zhong H; Rakheja D; Cai Q; Pedrosa I; Margulis V; Xu L; Kinch L; Brugarolas J
    Adv Anat Pathol; 2021 Jul; 28(4):251-257. PubMed ID: 34009776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TFEB Rearranged Renal Cell Carcinoma: Pathological and Molecular Characterization of 10 Cases, with Novel Clinical Implications: A Single Center 10-Year Experience.
    Wang AX; Tian T; Liu LB; Yang F; He HY; Zhou LQ
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China.
    Guo Q; Liu N; Wang F; Guo Y; Yang B; Cao Z; Wang Y; Wang Y; Zhang W; Huang Q; Zhao W; Liu C; Qu T; Li L; Cao L; Ren D; Meng B; Qi L; Wang C; Cao W
    Virchows Arch; 2021 Mar; 478(3):449-458. PubMed ID: 32918598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Eosinophilic solid and cystic renal cell carcinoma with TSC2 gene mutations in children].
    Yang WP; Chang KTE; Xu HY; Kuick CH; Ng EHQ; Huang H; Xiong F; Wu Y; Zeng ST; Fan JX; Loh XY
    Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):693-698. PubMed ID: 32610380
    [No Abstract]   [Full Text] [Related]  

  • 31. Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney.
    Kapur P; Gao M; Zhong H; Chintalapati S; Mitui M; Barnes SD; Zhou Q; Miyata J; Carrillo D; Malladi VS; Rakheja D; Pedrosa I; Xu L; Kinch L; Brugarolas J
    Mod Pathol; 2022 Mar; 35(3):333-343. PubMed ID: 34538873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
    Almutairi F; Xu B
    Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic utility of immunohistochemistry in differential diagnosis of renal tumors with oncocytic features].
    Zhang W; Yu WJ; Chen YQ; Kang EH; Liu Y; Zhuang J; Jiang YX; Chu J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):692-697. PubMed ID: 27760610
    [No Abstract]   [Full Text] [Related]  

  • 34. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
    Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and pathologic features of tubulocystic carcinoma of kidney].
    Zhang SH; Shi SF; Huang SF; Zhang YN; Zheng YY; Chen GY
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):543-6. PubMed ID: 23157747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
    Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
    Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Eosinophilic, solid, and cystic renal cell carcinoma (ESC-RCC)].
    Hartmann A; Agaimy A
    Pathologe; 2021 Nov; 42(6):565-570. PubMed ID: 34550432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathological and molecular genetic characteristics of ELOC mutated renal cell carcinoma].
    Wen Z; Zhang WH; Liang JY; Chai J; Wang YM; Xu WN; Wang Z; Fan LN
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1204-1209. PubMed ID: 38058035
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinicopathological Findings on 28 Cases with XP11.2 Renal Cell Carcinoma.
    Kuthi L; Somorácz Á; Micsik T; Jenei A; Hajdu A; Sejben I; Imre D; Pósfai B; Kóczián K; Semjén D; Bajory Z; Kulka J; Iványi B
    Pathol Oncol Res; 2020 Oct; 26(4):2123-2133. PubMed ID: 31955345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases.
    Tretiakova MS
    Hum Pathol; 2018 Oct; 80():65-75. PubMed ID: 29885406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.